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Capability of 2 Gait Measures for Detecting Response to Gait
Training in Stroke Survivors: Gait Assessment and
Intervention Tool and the Tinetti Gait Scale
Janice Zimbelman, PhD, Janis J. Daly, PhD, MS, Kristen L. Roenigk, BME, Kristi Butler, MSPT,
Richard Burdsall, PT, John P. Holcomb, PhD
Objective: To characterize the performance of 2 observa-
tional gait measures, the Tinetti Gait Scale (TGS) and the Gait
Assessment and Intervention Tool (G.A.I.T.), in identifying
improvement in gait in response to gait training.
Design: In secondary analysis from a larger study of multi-
modal gait training for stroke survivors, we measured gait at
pre-, mid-, and posttreatment according to G.A.I.T. and TGS,
assessing their capability to capture recovery of coordinated
gait components.
Setting: Large medical center.
Participants: Cohort of stroke survivors (N44) greater than
6 months after stroke.
Interventions: All subjects received 48 sessions of a multi-
modal gait-training protocol. Treatment consisted of 1.5 hours
per session, 4 sessions per week for 12 weeks, receiving these
3 treatment aspects: (1) coordination exercise, (2) body
weight–supported treadmill training, and (3) overground gait
training, with 46% of subjects receiving functional electrical
stimulation.
Main Outcome Measures: All subjects were evaluated with
the G.A.I.T. and TGS before and after completing the 48-
session intervention. An additional evaluation was performed
at midtreatment (after session 24).
Results: For the total subject sample, there were significant
pre-/post-, pre-/mid-, and mid-/posttreatment gains for both the
G.A.I.T. and the TGS. According to the G.A.I.T., 40 subjects
(91%) showed improved scores, 2 (4%) no change, and 2 (4%)
a worsening score. According to the TGS, only 26 subjects
(59%) showed improved scores, 16 (36%) no change, and 1
(2%) a worsening score. For 1 treatment group of chronic
stroke survivors, the TGS failed to identify a significant treat-
ment response to gait training, whereas the G.A.I.T. measure
was successful.
Conclusions: The G.A.I.T. is more sensitive than the TGS for
individual patients and group treatment response in identifying
recovery of volitional control of gait components in response to
gait training.
GAIT ASSESSMENT IS an important component of therehabilitation process. Instrumented gait assessment meth-
ods provide quantitative measures of gait kinematics, kinetics,
and electromyographic activity of muscles. There is no doubt
as to the superior advantage of instrumented gait assessment
methods with respect to their quantitative nature and the pos-
sible degree of accuracy. However, despite the advantages, the
literature contains multiple research studies that have used
observational gait analysis methods, and in the clinical setting,
observational gait analysis is routinely used. There are a num-
ber of reasons why instrumented gait analysis is not used in
every research study nor routinely used in clinical practice. It is
expensive, time intensive, and requires skilled analysis and
interpretation,1-4 which can limit its practicality. The advantage
of observational gait analysis, in general, has been that it is
inexpensive and requires little or no technology. At the same
time, the disadvantage of observational gait analysis versus
instrumented gait analysis methods is that it has a lesser accu-
racy resolution. A criticism of observational gait analysis meth-
ods has been with regard to the relationship (or lack thereof) to
the kinematic gait components they claim to measure. Stud-
ies5-11 examining correlations between visual judgments and
kinetic or kinematic measures are equivocal. Some have shown
that because observational gait analysis depends on human
visual judgment, it can be less reliable and less valid than
instrumented gait measures,1,3 although others have reported
high correlations between visual judgments and biomechanical
measures.6,8-10 Despite this limitation, the fact is that observa-
tional gait analysis is widely used in clinical and research
settings because of its ease of use and practicality.
List of Abbreviations
APTA American Physical Therapy Association
BWSTT body weight–supported treadmill training
CI confidence interval
FES-IM intramuscular functional electrical stimulation
G.A.I.T. Gait Assessment and Intervention Tool
ICC intraclass correlation coefficient
OG overground gait training
TGS Tinetti Gait Scale
Since observational gait analysis is currently in use, it is
important to use the optimal tool for the purpose at hand. A
number of observational gait measures exist including the
Wisconsin Gait Scale,12,13 Modified Gait Abnormality Rating
Scale,9 Rivermead Visual Gait Index,14 Rancho Observational
Gait Analysis,15 Bath Assessment of Walking Inventory,16
Tinetti Gait Scale (TGS),17 and Gait Assessment and Interven-
tion Tool (G.A.I.T.).10 Both the Gait Abnormality Rating Scale
and the G.A.I.T. have shown good (r.75 and r.76, respec-
tively) correlation with selected kinematic measures.9,10 Each
of these observational measures has advantages and limita-
tions, and each is capable of identifying a number of gait
deviations; however, some may be more sensitive than others
in assessing response to interventions for alleviating gait devi-
ations.
For assessing response to interventions, a credible tool is one
that correctly identifies clinically relevant deviations from nor-
mal gait and quantifies relevant changes in gait as a result of an
intervention.3 Without reliable measurement performance, we
forfeit 2 kinds of important capabilities: (1) the ability to credit
efficacious rehabilitation methods, and (2) the ability to justify
the financial support for providing effective gait training inter-
ventions. The StrokeEdge Taskforce of the American Physical
Therapy Association (APTA) Neurology Section recently rec-
ommended the TGS for use in research gait assessment,18 as
the preferred gait assessment tool. The G.A.I.T. is a more
recently developed tool for gait assessment.10 It is more de-
tailed, containing more items than the TGS, in order to assess
specific coordinated gait movements (31 vs 8 items). The
G.A.I.T. is more homogeneous than the TGS, in that it contains
items that assess coordinated gait components; that is, given
items contain both the spatial and temporal aspects of coordi-
nation19 (eg, amount of knee flexion [spatial] at midswing
[temporal]), and it captures the amount of deviation from
normal gait coordination. In contrast, the TGS includes given
items that assess only the temporal aspect of gait description
(eg, step length) or compensatory strategies such as gait asym-
metry or step discontinuity. The brevity and heterogeneity of
the TGS may limit its ability to detect some changes in gait in
response to gait training. Despite this potential limitation, the
TGS is widely used in the literature20 and has been recom-
mended by the APTA as the scale to use in research gait
assessment.18 Therefore, the purpose of the current work was to
use secondary analysis to assess the performance of 2 obser-
vational gait measures, the TGS and the G.A.I.T., to identify
changes in gait in response to gait training.
METHODS
Participants
A cohort of 44 subjects were evaluated, who were enrolled
in a gait-training trial described elsewhere.21 Inclusion criteria
were as follows: greater than 6 months after a single stroke;
inability to flex the hip, knee, and ankle normally in the sagittal
plane, or hyperflexion or hyperextension of the knee during
stance; and passive joint range of motion of the hip, knee, and
ankle equal to the normal excursion needed for walking. Ex-
clusion criteria included an inability to follow 2-level com-
mands, peripheral neuropathy, and debilitating illness (eg, can-
cer). The study was approved by the medical center
institutional review board, and a written informed consent
process was conducted.
Intervention
All subjects received 48 sessions of gait training using a
multimodal protocol as part of a clinical trial comparing intra-
muscular functional electrical stimulation (FES-IM) and no
FES (46% received FES).21 Treatment consisted of 1.5 hours
per session, 4 sessions per week for 12 weeks, and included
these 3 treatment aspects: (1) coordination exercise, (2) body
weight–supported treadmill training (BWSTT), and (3) over-
ground gait training (OG), with 46% of subjects receiving
FES-IM. Exercise included practice of the coordinated joint
movements that underlie gait components.22 BWSTT was con-
ducted using the Biodex500,a beginning with 30% body weight
support and decreasing to 0%, according to the subject’s ability
to maintain normal, neutral alignment of the torso and stance
limb. Walking training speed was increased up to .894m/s, as
tolerated. OG included training in the following: torso, pelvic,
hip, knee, and ankle position control during loading and weight
bearing; swing hip, knee, and ankle flexion; and terminal swing
knee extension/ankle dorsiflexion. Home exercises were coor-
dination exercises performed for 1h/d. FES-IM was used to
treat pelvic stability during stance phase, knee extension at
loading, ankle dorsiflexion during swing, knee flexion at toe-
off, and knee flexion during swing.23-25
Measures
The G.A.I.T. contains 31 items of coordinated gait compo-
nents, divided into 3 sections: Section A contains 4 items for
upper extremity and trunk movement control that occur during
both stance and swing phase; Section B contains 14 items for
the trunk and lower extremity that are unique to stance phase;
and Section C contains 13 items for the trunk and lower
extremity that are unique to swing phase.10 Deviations from
normal are listed as scoring choices within each item. Scoring
for each item ranges from 0 (normal) up to 3, with deviations
from normal defined and scored as 1, 2, or 3 points. The
G.A.I.T. ranges from 0 (normal) to 62 points (greatest extent of
gait deviations). The G.A.I.T. has good intrarater reliability26
(intraclass correlation coefficient [ICC].98; P.0001; 95%
confidence interval [CI], .95–.99) and good interrater reliability
(ICC.83; P.007; 95% CI, .32–.96).10 Items on the G.A.I.T.
demonstrated significant correlations with motion capture data
for knee flexion at toe-off (r.65, P.001) and peak swing
knee flexion (r.76, P.0001).10 The G.A.I.T. was developed
by 8 experienced physical therapist clinicians10 as a detailed
observational measure of coordinated gait components to quan-
tify response to gait training interventions.10 With a scoring
time of 20 minutes, the G.A.I.T. has been tested and can be
used in a relatively low tech environment with a video camera
to record the gait pattern and a video player with “playback,”
“stop-frame” capability for scoring some items.
The TGS contains 8 items assessing the following: deficits in
coordinated gait components (2 items), compensatory strate-
gies (5 items), and temporal aspects of gait (1 item).17 Six items
are scored as 0 (deviation) or 1 (normal) point; 2 items are
scored as 0, 1, (deviations), or 2 (normal) points. The TGS
ranges from 0 (most deviations) to 12 points (normal). The
TGS has good interrater reliability (r.80–.89), moderate to
good test-retest reliability (r.72–.77),27 and good intrarater
reliability (r.95).28 The TGS was originally developed to
identify abnormal gait17 and takes 5 minutes to score. We
chose to compare the G.A.I.T. with the TGS because the TGS
is used widely in research studies20 and has been recommended
by the APTA as the observational measure of choice for
research gait assessment.18
Testing
Twelve subjects ambulated without an assistive device on
entering the study; 31 subjects ambulated with an assistive
device (table 1). Each given subject was consistently tested at
pre-/mid-/posttreatment tests (and without FES-IM), using
their own consistent assistive device at each test session. The
examiners in this study were physical therapists with more than
10 years of experience in clinical practice and gait assessment,
and more than 3 years of experience in using the G.A.I.T. and
TGS measures. For a given subject, the examiner was consis-
tent for pre-/mid-/posttreatment measures, and the same exam-
iner scored both the G.A.I.T. and the TGS measures. The
examiners were blinded as to the purpose of the study.
Data Analysis
Overall change scores (pretreatment minus posttreatment;
pretreatment minus midtreatment; midtreatment minus post-
treatment) were calculated for the G.A.I.T. and the TGS. A
change score was also calculated for each item for each mea-
sure. We generated descriptive statistics to examine the distri-
bution of total and item change scores for each measure. The
Wilcoxon signed-rank test was used for the following compar-
isons: pre-/post-, pre-/mid-, and mid-/posttreatment scores. The
Sidak step-down procedure was used to correct for multiple
comparisons. Correlation between gait coordination and gait
speed was calculated using measured gait speed (m/s) and the
G.A.I.T., using the Spearman model; this was repeated for the
TGS and measured gait speed.
RESULTS
Total Score Analysis
The G.A.I.T. detected a significant pre-/posttreatment gain
(P.0001; pre-/posttreatment median and interquartile range
were 33.75 [9.75] and 25.5 [8.625], respectively); G.A.I.T.
gain scores ranged from 1 (worsening) to 17 (improve-
ment) points. The TGS also detected a significant pre-/post-
treatment gain (P.0001; pre-/posttreatment median and inter-
quartile range were 6.0 [3.0] and 8.0 [3.0], respectively); TGS
gain scores ranged from 3 (worsening) to 6 (improvement)
points. Descriptive statistics for the individual subject change
scores for each measure revealed that 40 (91%) of the 44
subjects showed improved scores according to the G.A.I.T., 2
(4%) showed no change, and 2 (4%) showed a worsened score.
According to the TGS, 26 (59%) of the 44 subjects showed
improved scores, 16 (36%) showed no change, and 1 (2%)
showed a worsened score (fig 1). Figure 1 shows that there was
a difference for the TGS versus the G.A.I.T. regarding the
number of subjects who had no recovery of gait component
performance. The G.A.I.T. measure identified that only 11.4%
of subjects had none to minimal gains (0–1 point), whereas the
TGS suggested that 56.8% of subjects had none to minimal
gains.
We conducted a secondary exploratory descriptive analysis
to equilibrate the difference in the 2 scales, specifically the
G.A.I.T., which has a total score of 62 points, and the TGS,
which has a total score of 12 points (5:1 ratio). We can note that
a 1-point gain on the TGS could be considered equivalent to a
5-point gain on the G.A.I.T. Using this algorithm, we found
that 28 (63.6%) of the 44 subjects demonstrated greater than a
5-point pre-/posttreatment G.A.I.T. gain, which was greater
than the 17 (38.6%) subjects demonstrating greater than a
1-point pre-/posttreatment TGS gain.
The G.A.I.T. detected a significant pre-/midtreatment gain
(P.001; pre-/midtreatment median and interquartile range
were 33.75 [9.75] and 28.5 [9.0], respectively) and a significant
mid-/posttreatment gain (P.0001; mid-/posttreatment median
and interquartile range, 28.5 [9.0] and 25.5 [8.625], respec-
tively). The TGS also detected a significant pre-/midtreatment
gain (P.0001; pre-/midtreatment median and interquartile
Table 1: Initial Ambulatory Status Used for Pre-, Mid-, and
Posttreatment Testing
Assistive Device No. of Subjects
No assistive device 12
Standard cane 15
Small-based cane 4
Large-based cane 8
Large-based cane and AFO 3
Parallel bars/hemi-walker 1*
Abbreviation: AFO, ankle-foot orthosis.
*One subject used parallel bars at pretreatment, of necessity, and a
hemi-walker at posttesting.
Fig 1. Individual subject change
scores for the G.A.I.T. and the TGS.
Each circle represents a single sub-
ject; positive numbers indicate
gain, negative numbers indicate
loss.
range were 6.0 [3.0] and 7.0 [2.0], respectively) and a signif-
icant mid-/posttreatment gain (P.006; mid-/posttreatment
median and interquartile range, 7.0 [2.0] and 8.0 [3.0], respec-
tively). Both the G.A.I.T. and the TGS were correlated with
gait speed ([r.735, P.0001] and [r.739, P.0001], re-
spectively).
For gait speed, there was a statistically significant pre-/
midtreatment gain (P.0001; pre-/midtreatment mean  SD,
.396.245m/s and .477.284m/s, respectively). But the gain
in gait speed from pre-/midtreatment was .08m/s, which is
below the current standard of .16m/s for a minimally clinically
significant change.29 There was a significant mid-/posttreat-
ment gain (P.001); mid-/posttreatment mean  SD values
were .477.284m/s and .536.329m/s, respectively. How-
ever, the gain in gait speed from mid-/posttreatment was
.06m/s, which is below the current standard of .16m/s for a
minimally clinically significant change.29 The overall pre-/
posttreatment gait speed gain was statistically significant
(P.0001), with mean  SD values of .396.245m/s and
.536.329m/s, respectively. However, the gain in gait speed
from pre-/posttreatment was .14m/s, which is slightly below
the current standard of .16m/s for a minimally clinically sig-
nificant change.29
Individual Item Scores
The item content for both measures is listed in table 2,
drawing potential commonalities for the G.A.I.T. and the TGS
items. Although not a one-to-one commonality, the TGS item
“step length and height” may be affected by the extent of
movement excursion for swing phase hip flexion and/or knee
flexion and/or ankle dorsiflexion; these latter 3 components are
measured as separate items in the G.A.I.T., but the effects of
these 3 items are considered as only a single item in the TGS.
The G.A.I.T. measures trunk posture during both swing and
stance phases, and within 2 different planes (sagittal and cor-
onal), resulting in 4 individual items; the TGS measures trunk
sway as a single item. Table 3 lists the items that are unique to
either of the measures.
Individual items of each measure were able to distinguish
gains. Table 4 lists the items for each measure that captured a
gain score of 1 point or more. Twenty-eight (90%) of the 31
Table 2: Items Common to Both Measures
G.A.I.T. Items Comparable With TGS Items TGS Items Comparable With G.A.I.T. Items
Item No. Item Description Item No. Item Description
24 Hip flexion (swing phase) 2 Step length and height—swing foot
27 Knee—midswing 2 Step length and height—swing foot
29 Ankle movement (swing phase) 2 Step length and height—swing foot
5 Trunk posture (stance phase; sagittal plane) 7 Trunk sway
6 Trunk posture (stance phase; coronal plane) 7 Trunk sway
19 Trunk posture (swing phase; sagittal plane) 7 Trunk sway
20 Trunk posture (swing phase; coronal plane) 7 Trunk sway
Table 3: Items Unique to Each Measure
G.A.I.T. Items Not in TGS TGS Items Not in G.A.I.T.
Item No. Item Description Item No. Item Description
1 Shoulder position (stance and swing) 1 Initiation of gait
2 Elbow flexion (stance and swing) 4 Step symmetry
3 Arm swing (stance and swing) 5 Step continuity
4 Trunk alignment (static) 6 Path
7 Weight shift (stance phase) 8 Step width
8 Pelvic position (stance phase)
9 Hip extension (stance phase)
10 Hip rotation (stance phase)
11 Knee—initial contact phase
12 Knee—loading response phase
13 Knee—midstance phase
14 Knee terminal/preswing phase
15 Ankle movement (stance phase)
16 Ankle inversion (stance phase)
17 Plantar flexion during terminal/preswing
18 Toe position (stance phase)
21 Pelvic position (swing phase; coronal plane)
22 Pelvic position (swing phase; sagittal plane)
23 Pelvic rotation as limb swings forward
25 Hip rotation (swing phase)
26 Knee—initial swing
30 Ankle inversion (swing phase)
31 Toe position (swing phase)
G.A.I.T. items, and all 8 TGS items were able to capture gains
in at least 1 subject.
Treatment Effect for Each FES-IM and No FES Group
We examined the capability of the G.A.I.T. and TGS to
detect a significant treatment effect for those who did not
receive FES-IM (No FES, n24) and those who did receive
FES-IM (n20). Results of this analysis are in table 5. Both
measures were able to detect significant change in pre-/post-
treatment scores in both the FES-IM and No FES groups. In
addition, both measures detected significant change in pre-/
midtreatment scores for both groups; however, only the
G.A.I.T. detected significant continued change from mid- to
posttreatment.
DISCUSSION
Results showed that both measures were able to detect
significant pre-/posttreatment gains in response to gait retrain-
ing in a group of 44 subjects with stroke. Both measures were
able to identify change in some individual subjects as shown in
figure 1. However, the G.A.I.T. identified improvement in a
much larger percentage of the subjects compared with the TGS
(91% vs 59%). In fact, only 2 subjects showed no change in
their total G.A.I.T. score; in contrast, 16 subjects showed no
change according to the TGS. Justification of treatment has
become critical in terms of obtaining insurance coverage for
rehabilitation; when there is no credible progress measured,
treatment is not continued. Notably, figure 1 shows that ac-
Table 4: Items in Which Subjects Exhibited Gain Scores on the G.A.I.T. or TGS
G.A.I.T. Items TGS Items
Item
No. Item Description
No. of
Subjects
% of
Subjects
Item
No. Item Description
No. of
Subjects
% of
Subjects
1 Shoulder position 2 4% 1 Gait initiation 5 11%
2 Elbow flexion 6 13% 2 Step length and height—right swing foot 17 39%
4 Trunk alignment (static) 18 41% 3 Step length and height—left swing foot 13 30%
5 Trunk posture (stance phase; sagittal plane) 15 34% 4 Step symmetry 11 25%
6 Trunk posture (stance phase; coronal plane) 12 27% 5 Step continuity 10 23%
7 Weight shift (stance phase) 16 36% 6 Path (deviation from or uses walking aid) 7 16%
8 Pelvic position (stance phase; coronal plane) 4 9% 7 Trunk sway 7 16%
9 Hip extension (stance phase) 9 20% 8 Step width 8 18%
10 Hip rotation (stance phase) 8 18%
11 Knee—initial contact phase 15 34%
12 Knee—loading response phase 11 25%
13 Knee—midstance phase 18 41%
14 Knee terminal/preswing phase 18 41%
15 Ankle movement (stance phase) 10 23%
16 Ankle inversion (stance phase) 10 23%
17 Plantar flexion terminal stance 9 20%
19 Trunk posture (swing phase; sagittal plane) 10 23%
20 Trunk posture (swing phase; coronal plane) 12 27%
21 Pelvic position (swing phase; coronal plane) 14 32%
22 Pelvic position (swing phase; sagittal plane) 4 9%
23 Pelvic rotation as limb swings forward 12 27%
24 Hip flexion (swing phase) 12 27%
25 Hip rotation (swing phase) 13 30%
26 Knee—initial swing 13 30%
27 Knee—midswing 12 27%
28 Knee—terminal swing 4 9%
29 Ankle movement (swing phase) 11 25%
30 Ankle inversion (swing phase) 16 36%
Table 5: Capability of TGS and G.A.I.T. Measures to Detect Significant Improvement From Pre- to Midtreatment and
From Mid- to Posttreatment for Each of Two Treatment Groups
Pre- to Midtreatment Comparison Mid- to Posttreatment Comparison Pre- to Posttreatment Comparison
Pre Median
(IQR)
Mid Median
(IQR) P
Corrected
P
Mid Median
(IQR)
Post Median
(IQR) P
Corrected
P
Pre Median
(IQR)
Post Median
(IQR) P
Corrected
P
G.A.I.T.
FES 33.75 (9.75) 28.00 (8.75) 0.003 0.009 28.00 (8.75) 25.00 (7.75) 0.001 0.004 33.75 (9.75) 25.00 (7.75) 0.0001 0.0004
No FES 33.50 (9.75) 31.50 (7.37) 0.036 0.036 31.50 (7.38) 27.50 (9.00) 0.004 0.012 33.50 (9.75) 27.50 (9.00) 0.0001 0.0004
TGS
FES 6.0 (2.75) 7.0 (2.5) 0.002 0.008 7.0 (2.5) 8.0 (2.75) 0.026 0.051* 6.0 (2.75) 8.0 (2.75) 0.002 0.002
No FES 5.0 (3.00) 6.0 (3.0) 0.003 0.009 6.0 (3.0) 6.0 (3.00) 0.131 0.131* 5.0 (3.00) 6.0 (3.00) 0.001 0.004
Abbreviation: IQR, interquartile range.
*No significant difference detected.
cording to the TGS, treatment would be terminated for 56.8%
(25) of the subjects (0- to 1-point change in response to
treatment), whereas treatment would be terminated for only
11.4% (5) of the individuals according to the G.A.I.T. measure.
In that case, 20 individuals would be deprived of treatment that
would have had a positive effect on their coordinated gait.
These results indicate that the G.A.I.T. was more sensitive than
the TGS in discriminating actual change in coordination of
walking ability.
We further examined the capability of the G.A.I.T. and TGS
to detect change for each of 2 treatment groups (FES-IM and
No FES). Table 5 shows that the TGS detected significant
change only during the first 24 sessions, but not for the sub-
sequent 24 sessions from mid- to posttreatment. In contrast, the
G.A.I.T. detected significant change not only during the first 24
sessions, but also during the latter 24 sessions. This finding
illustrates that if only the TGS were used to examine treatment
efficacy, it would erroneously be concluded that subjects had
plateaued by the end of the first 24 sessions and did not have
any further recovery during the latter 24 sessions. If guidelines
were based on that information, stroke survivors would be
deprived of efficacious gait training. Moreover, the G.A.I.T.
results not only indicate that recovery continued throughout the
latter 24 sessions, but also point to the possibility that even
additional gait training might be beneficial and lead to further
recovery. According to the G.A.I.T. measure, since there was
no plateau between mid- and posttreatment, justification for
follow-up research questions is revealed as follows: (1) how
much more gait training would be beneficial? and (2) how
much more recovery could be achieved?
There are several reasons why the G.A.I.T. may be more
sensitive than the TGS. First, the G.A.I.T. is more homoge-
neous than the TGS. Item content for the TGS includes not
only coordinated gait components (step length/height), but also
compensatory strategies such as abnormal step width, gait
asymmetry, and step discontinuity (see table 3). Subjects may
have improved on some coordinated gait components measured
by the G.A.I.T., but perhaps not all the gait components en-
compassed by the more global compensatory strategies as-
sessed by the TGS. For example, subjects improved weight
shift and pelvic position as measured with the G.A.I.T., but still
had some balance deficit that required the compensatory strat-
egy of an abnormally wide step width measured by the TGS.
Second, the G.A.I.T. is more detailed, containing more items
and possessing a higher total score (31 items, 62 points) than
the TGS (8 items, 12 points). Table 3 shows that the G.A.I.T.
possesses a greater number of unique items versus the TGS.
Hip, knee, and ankle excursion during the swing phase of gait
each have the ability to affect step length and height. These
individual joint excursions are measured and scored separately
as individual items in the G.A.I.T., whereas the effects of these
3 items are considered together in only 1 global item (step
length and height) in the TGS. In other words, step length and
height are assessed by the TGS, but the specific coordinated
means that were used to achieve normal step length and height
are not measured. Without the identification of the specific gait
dyscoordination, and recovery thereof, the clinician and the
researcher are not provided with clear guidance for gait coor-
dination training and with clear research evidence, respec-
tively.
A second example of the advantage of a more detailed
measure is that the G.A.I.T. has 14 items to assess trunk,
pelvic, hip, knee, and ankle coordination gait components
during the stance phase of gait, and 13 items for coordination
gait components during the swing phase of gait. The TGS has
1 item assessing stance phase of gait (step width) and 2 items
assessing swing phase: right step length/height and left step
length/height. As shown in table 4, at least 10 subjects dem-
onstrated improvement on 9 stance and 10 swing phase gait
component movements according to the G.A.I.T. measure;
however, the 1 relevant swing-phase coordination item in the
TGS was not constructed in a manner that was sufficient to
capture those gains. For example, the improved knee flexion in
swing phase that was captured by the G.A.I.T. measure may
not have been sufficient for detection by the TGS, which
required recovery of whole-limb performance to detect change
in the more gross-movement TGS item.
A third reason why the G.A.I.T. measure is more sensitive
may be that the G.A.I.T. is capable of measuring incremental
changes within given gait components. Twenty-four of the
G.A.I.T. items require a determination of the degree of the
deficit. The G.A.I.T. was designed in this way to capture an
incremental response to treatment within the domain of the
given gait component. For example, the item “knee-midswing”
is rated as 0 (60°, normal), 1 (45°–55°), 2 (25°–45°), or 3
(0°–25°) depending on the amount of knee flexion performed.
During treatment, a patient may improve gradually, over time,
in the amount of knee flexion executed at midswing. The
capability of a gait measure to show incremental change over
time allows the clinician to document that the patient has not
yet plateaued and deserves more treatment for the measured
rehabilitation potential. Accurately identified gains illustrate
for the researcher that a new protocol is efficacious and/or that
full recovery may not have yet been reached and study is
warranted of additional treatment duration. The incremental
improved knee flexion would be reflected in a change score in
the G.A.I.T. However, for the TGS, this incremental improve-
ment in knee flexion cannot be captured, and it would appear
that the patient had not responded to intervention. In that case,
promising treatment would be denied to a patient who actually
was exhibiting progress (but unmeasured) and potential for
further recovery. In the realm of research, a potentially effica-
cious treatment might be inaccurately classified as not benefi-
cial, if incremental gains are not identified.
Gait measures should not only determine whether a deficit
exists, but also assist in clinical decision-making, guiding treat-
ment decisions. The TGS was designed as a clinical measure to
detect obvious problems with gait (ie, identify abnormal
gait).17 Its advantage is that it is simple to use, only takes a few
minutes to administer, and does identify obvious problems with
gait. However, because it is not comprehensive, it is not able to
guide treatment decisions aimed at recovery of gait coordina-
tion and normal walking ability. A measure such as the
G.A.I.T. that is comprehensive is able to guide treatment by
assisting the therapist with identifying deficits in specific gait
components. For example, the TGS will identify a deficit in the
ability to bring the swing foot past the stance foot (abnormal
gait characteristic). However, the G.A.I.T. provides the thera-
pist with an assessment tool and a score regarding whether this
inability is due to insufficient hip, knee, or ankle dorsiflexion
during swing or insufficient hip or knee extension during
stance, or abnormal weight shift during stance. Any of these
deficits lead to the 1 deficit measured by the TGS single item
(bringing the swing foot past the stance foot). The G.A.I.T.
provides a means to analyze several sources of the gait deficits,
providing a guide to focus on specific training options to
improve gait performance.
Gait speed is widely recommended as an outcome measure
in the poststroke gait literature, and some would argue that it is
the criterion standard measurement for “gait function.”30-32
According to gait speed (m/s) results in the current study, there
was a statistically significant gain for the paired comparisons
between each of the data acquisition time points (pre-/mid-/
posttreatment). Some have reported that a gait speed gain of .16
m/s is a minimal clinically important difference that can be
used by clinicians to develop goals and interpret progress in
patients after stroke.29 If that criterion were exclusively used in
the current study, we would have to conclude that none of the
comparisons (pre-/posttreatment; pre-/midtreatment; and mid-/
posttreatment) reached a gain in gait speed of .16m/s, and so
were not clinically significant. Gait speed is related in a number
of ways to gait coordination. Gait coordination can be consid-
ered a higher order property of the human system, controlled
by the central nervous system.19 The relationship between gait
coordination and gait speed is complex. We do know that
normally coordinated gait results in a self-selected gait speed
averaging 1.39m/s,33,34 which is the optimal walking speed in
terms of energy expenditure.35 We also know that impaired gait
coordination can lead to abnormally reduced gait speed as well
as poor walking endurance after stroke. Some stroke survivors
can adopt compensatory strategies such as hip hiking and
circumducting that can be observed in a “stiff-legged” gait.
These compensatory strategies may enable a faster walking
speed,36 but at the same time, they are less efficient in terms of
energy cost versus normal gait coordination37 and can be less
desirable for a number of reasons19 such as poor safety and
propensity to fall.25 The complex relationship between gait coor-
dination and gait speed justifies the use of both types of measures
in analyzing gait deficits and response to gait training.
Study Limitations
There are a number of available tools for characterizing and
measuring gait coordination. It was beyond the scope of the
current study to assess them all. This study was focused to
study 2 observational gait measures. We selected the G.A.I.T.
because it is a detailed and homogeneous measure of coordi-
nated gait components that informs the therapist of gait devi-
ations and provides a mechanism to evaluate progress and
establish treatment goals for gait training. We selected the TGS
because it is widely used in the literature and was recom-
mended by the APTA StrokeEdge Taskforce as the observa-
tional gait measure of choice for research. The study sample
was limited to 44 stroke survivors who were 6 months post-
stroke. The gait-training protocol that produced the pre-/post-
treatment scores was confined to the combination of exercise,
BWSTT, and OG, with or without FES-IM, depending on
assignment. The types of measures were limited to 2 observa-
tional gait coordination measures and gait speed.
CONCLUSIONS
In the current health care environment, it is critical to mea-
sure response to interventions in a manner that is accurate,
comprehensive, and sensitive to incremental change. Without
this capability, we forfeit the ability to credit efficacious reha-
bilitation interventions and to justify the financial support of
providing effective gait-training methods. The current study
demonstrated that the G.A.I.T. is more sensitive for individual
stroke survivors than the TGS in identifying improvement in
volitional control of gait component coordination in response
to gait training. We found that the TGS missed the accurate
identification of recovery of gait coordination in a large per-
centage of stroke survivors. The G.A.I.T. exhibited better ca-
pability than the TGS in identifying a significant response to
treatment for a group of chronic stroke survivors.
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